# Madrigal Pharmaceuticals, Inc.: Form DEF 14A, filed May 2, 2022

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: DEF 14A
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 11:40 ET
- Period: 2022-06-15
- Accession: 0001193125-22-136035
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000119312522136035/d289121ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000119312522136035/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000119312522136035/d289121ddef14a.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-136035. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.
